drugset / Trial / NCT00004216
VNP20009 in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Therapy
Treatment
Summary
RATIONALE: Biological therapies such as VNP20009 use different ways to stimulate the immune system and stop cancer cells from growing. PURPOSE: Phase I trial to study the effectiveness of VNP20009 in treating patients who have advanced or metastatic solid tumors that have not responded to previous therapy.
Timeline
- Start
- 1999-08
- Primary completion
- —
- Completion
- 2008-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VNP20009 | Other / unclassified | — | Other |
| Background | Cefixime | Other / unclassified | — | Oral |
| Background | Ceftriaxone | Other / unclassified | — | Intravenous |
| Background | Ciprofloxacin | Small molecule | — | Intravenous |
| Background | trimethoprim-sulfamethoxazole | Unknown | — | Oral |